Weight Loss And Obesity Management Market Size 2019: Global Trends, Key Players, Share, Future Perspective, Emerging Technologies And Analysis By Forecast

Weight Loss And Obesity Management Market Size 2019:  Global Trends, Key Players, Share, Future Perspective, Emerging Technologies And Analysis By Forecast

“Obesity Management Market”
Obesity Management Market 2019: Size To Expand at a Notable CAGR Of 8.4% During to 2022 | MRFR

Global Obesity Management Market Overview

Obesity is an illness where an individual gains excessive fat which, in turn, affects the health adversely. Obesity management is an emerging market where various treatments, drugs, and surgical treatments are made available to treat and control obesity.

Free Sample PDF Available Here!! https://www.marketresearchfuture.com/sample_request/2690

It may include preventive and corrective measures taken by individuals with the help of healthcare organizations and experts. The report on obesity management market as published by Market Research Future states that the market is likely to garner a revenue of USD 6.2 billion, expanding at 8.4% CAGR by 2022. Various factors are fueling the growth of the obesity management market. Some of these factors include changing lifestyle and unhealthy eating habits that are driving the obesity treatment market through the forecast period.

The prevalence of obesity is upscaling at an alarming rate due to the emergence of a stressful lifestyle, coupled with unhealthy eating habits, further contributing to the ascension of the obesity treatment market. Also, drug manufacturers are generously investing in the research and development of anti-obesity drugs, fueling the growth in obesity management market.

Key Players

The global obesity management market is being driven by many prominent players including

  • Merck Sharp & Dohme Corp
  • Pfizer Inc
  • Ethicon
  • AstraZeneca
  • Apollo Endosurgery
  • Herbalife
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • GlaxoSmithKline

 

Detailed Regional Insights

The global obesity management market has been studied for various specific regional segments such as Europe, North America, Asia Pacific, and Rest of the World. Asia Pacific is estimated to proliferate at a rapid pace and is likely to dominate the obesity treatment market during the assessment period. Growth of the obesity management market in Asia Pacific is accredited to the lack of physical activity due to the adoption of a sedentary lifestyle, unhealthy life balance, and poor dietary habits. Further, the government is majorly encouraging the adoption of the latest technologies and advanced treatment, also initiating R&D activities for the development of new anti-obesity drugs. Emerging economies like China and India are seen as major country-specific markets owing to the presence of a massive patient pool and higher purchasing power as compared to other countries.

North America is anticipated to be the principal market for obesity management due to the presence of a huge percentage of obese population coupled with advanced treatment options. For instance, approximately 37.9% of all adults in North America were observed to be suffering from obesity from 2013-2014, as per the CDC. Moreover, more than 70% are suffering from being overweight.

Global Obesity Management Market: Segmental Analysis

The global obesity management market has been segmented on the basis of prescription, surgery, and lifestyle changes.

By mode of prescription, the obesity management market has been segmented into orlistat (Xenical), lorcaserin (Belviq), phentermine and topiramate (Qsymia), bupropion and naltrexone (Contrave), liraglutide (Saxenda), and others.

By mode of surgery, the obesity management market has been segmented into gastric bypass surgery, laparoscopic adjustable gastric banding (LAGB), biliopancreatic diversion with duodenal switch, and others. Among these, the gastric bypass surgery segment is estimated to be the fastest growing market owing to faster recovery time, improved psychological status, and improved longevity.

By mode of lifestyle changes, the global obesity management market has been segmented into dietary changes, exercise, and others.

 

Industry Update

February 2019: Gl Dynamics Inc. is a medical company that has developed EndoBarrier for obese patients who are suffering from type 2 diabetes. It has recently announced that they have acquired an approval from the Institutional Review Board (IRB) to conduct its pivotal trial of EndoBarrier.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @

https://www.marketresearchfuture.com/reports/obesity-management-market-2690

 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/sample_request/2690